Somer Bishop is a clinical psychologist and professor in residence of psychiatry at the University of California, San Francisco.
Somer Bishop
Assistant professor
University of California, San Francisco
From this contributor
Rethinking autism assessments in the time of COVID-19: Q&A with Bishop, Zwaigenbaum
Moving most clinical assessments online during the coronavirus pandemic has created a digital divide while closing some geographical ones, say Somer Bishop and Lonnie Zwaigenbaum.
Rethinking autism assessments in the time of COVID-19: Q&A with Bishop, Zwaigenbaum
Questions for Bishop, Havdahl: Tantrums trick autism tests
Children with low intelligence or behavioral issues — but not autism — may meet the criteria for autism on standard diagnostic tests.
Questions for Bishop, Havdahl: Tantrums trick autism tests
Seeking precise portraits of girls with autism
Researchers need to consider new ways of capturing how autism manifests in girls, who may find clever ways of camouflaging their symptoms.
Gauging intelligence in autism over time
Adapting traditional tests of intelligence for people with intellectual disability can deflate their scores over time. Somer Bishop calls for tests that more accurately assess intelligence in this group.
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.